Semaglutide SM15 15mg*10vials

Semaglutide SM15 (15mg x 10 vials) is an upgraded version of a high-purity, long-acting lyophilized GLP-1 receptor agonist peptide, suitable for preclinical laboratory studies. As an optimized iteration of the classic SM10 version, SM15 utilizes upgraded molecular modification technology, exhibiting higher receptor binding affinity, better bioactivity stability, and longer in vitro retention activity. Its optimized 15mg high-concentration single-vial size is perfectly suited for medium-to-high dose gradient experiments, long-term metabolic modeling, and batch-reproducible validation studies, making it a high-quality, upgraded raw material for in-depth research into the metabolic regulation mechanisms of GLP-1.

Product Functions and Research Value

Semaglutide SM15 possesses highly efficient and stable single-target activation of GLP-1, mimicking the body's physiological incretin activity. In laboratory studies, it is primarily used to explore core mechanisms such as glycemic homeostasis regulation, improvement of insulin sensitivity, and repair of insulin resistance. It can also stably regulate appetite signal inhibition, prolong satiety, reduce cumulative food intake, and intervene in lipid metabolism and adipose tissue accumulation. Compared to the basic SM10, SM15 offers more durable efficacy and a more stable experimental phenotype, providing more accurate and consistent data support for high-precision preclinical studies of glucose and lipid metabolism disorders, chronic metabolic diseases, and endocrine regulation.

Core Product Advantages

1. Upgraded SM15: The optimized molecular structure enhances target binding efficiency and anti-degradation ability, with higher activity stability than standard semaglutide and SM10, ensuring more reliable and reproducible experimental results.

2. Upgraded 15mg High-Concentration Specification: The single-vial content is higher than the conventional 10mg product, perfectly suited for medium/high dose comparison experiments, long-term reproducible animal model construction, and large-scale sample testing, effectively reducing errors caused by frequent reagent preparation.

3. Professional Vacuum Lyophilization Process: Utilizing aseptic vacuum lyophilization technology, it maximizes the preservation of peptide activity. Each batch undergoes rigorous HPLC purity testing and comes with complete COA quality certification, ensuring extremely low impurity content and excellent batch consistency. 4. Practical 10-bottle/box Packaging: Standardized 10-bottle/box packaging meets the needs of daily laboratory research, university research projects, long-term experimental storage, and bulk wholesale procurement.

Smigraglutide (SM15) 15mg*10-bottle pack is an upgraded version of a high-purity, long-acting lyophilized GLP-1 receptor agonist research peptide. As an upgrade to the classic SM10, SM15 utilizes advanced molecular modification technology, exhibiting stronger target binding affinity, higher bioactivity stability, and a longer in vitro activation duration. Packaged in high-concentration 15mg vials, SM15 is perfectly suited for medium-to-high dose gradient experiments, long-term metabolic modeling, and batch reproducible validation experiments, making it a high-quality, upgraded research raw material for in-depth research into the metabolic regulation mechanisms of GLP-1.

Core Uses and Research Value of the Peptide: SM15 can efficiently and stably activate the GLP-1 single-target pathway, mimicking the physiological activity of in vivo incretin, making it a core raw material for metabolic research. In research scenarios, SM15 is mainly used to explore core mechanisms such as glycemic homeostasis regulation, enhanced insulin sensitivity, and repair of insulin resistance. Simultaneously, SM15 can stably suppress appetite signals, prolong satiety, reduce cumulative food intake, and intervene in lipid metabolism and fat accumulation. Compared to the basic version of SM10, SM15 has a more durable effect and a more stable experimental phenotype, providing more accurate and consistent experimental data support for high-precision preclinical studies in areas such as glucose and lipid metabolism disorders, chronic metabolic diseases, and endocrine regulation.

Core Product Advantages:

1. SM15 Iteratively Upgraded Formulation: The optimized molecular structure significantly improves target binding efficiency and anti-degradation ability. Its bioactivity stability is superior to ordinary lectins and the basic version of SM10, greatly improving experimental reproducibility and reliability.

2. Upgraded 15mg High-Concentration Specification: Compared to the traditional 10mg specification, the single-vial dose is higher, perfectly suited for medium- to high-dose controls, long-term repetitive animal model construction, and large-scale sample experiments.